Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05383976 · ClinicalTrials.gov registry record
Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 385
- Enrollment target
NCT05383976: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT05383976 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 385 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05383976 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 385 participants
- Enrollment target
Study Summary
The overarching goal of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a persistent poverty county by designing, conducting, disseminating and evaluating an electronic health record-based automated identification program to target effective, culturally-sensitive CRC screening navigation to individuals who have not completed an ordered colonoscopy or fecal immunochemical test (FIT).
Primary Outcome
Number of patients that participate in the navigation program
Interventions
- OTHER Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2022-03-29 |
| Est. Completion | 2024-11-01 |
What the finished NCT05383976 record still lists
NCT05383976 is an observational study that tracks outcomes without assigning an intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program is the first listed.
NCT05383976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05383976 about?
NCT05383976 is a clinical study titled "Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)". The overarching goal of the "PCSNaP" Research Study is to support the Abramson Cancer Center (ACC) of the University of Pennsylvania in carrying out its mission to increase colorectal cancer (CRC) screening completion among high-risk individuals living in a persistent poverty county by designing, co...
What is the current status of trial NCT05383976?
This trial is currently completed. The enrollment target is 385 participants. The study started on 2022-03-29. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT05383976?
The interventions under investigation include: Machine Learning Algorithm with Existing Penn Medicine CRC Patient Navigation Program (OTHER).
Who is sponsoring clinical trial NCT05383976?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373823 · 385 participants · NA
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
- NCT05503173 · 385 participants · NA
Telehealth for Pain and Unhealthy Drinking Among PLWH
- NCT06226883 · 385 participants · Phase 2
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- NCT06290063 · 385 participants · Phase 2
Cannabidiol and Older Adult Cannabis Users
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI